Chronic renal allograft dysfunction: immunologic and nonimmunologic risk factors

By Golbabaie M.   Kayedi M.   Najafi I.   Ganji M.R.   Naderi G.H.   Mehraban D.   Hakemi M.  

Transplantation Proceedings, Vol. 33, Iss. 5, 2001-08 ,pp. : 2691-2692

Elsevier

Access to resources Recommend Favorite

Impact of atenolol consumption on the development of chronic renal allograft dysfunction

By Jahromi A.R.H.   Raissjalali G.A.  

Transplantation Proceedings, Vol. 35, Iss. 7, 2003-11 ,pp. : 2647-2649

Elsevier

Access to resources Recommend Favorite

Effects of peritransplant administration of hematopoietic growth factors on the development of chronic allograft rejection

By Terakura M.   Ye Q.   Ichikawa N.   Demetris A.J.   Sakamoto T.   Liu Z.   Starzl T.E.   Murase N.  

Transplantation Proceedings, Vol. 31, Iss. 1, 1999-02 ,pp. : 870-871

Elsevier

Access to resources Recommend Favorite

Mycophenolate mofetil in ongoing chronic kidney allograft dysfunction

By Senn B.   Rochat P.   Schwarzkopf A.K.   Weinreich T.   Binswanger U.  

Transplantation Proceedings, Vol. 30, Iss. 8, 1998-12 ,pp. : 4075-4076

Elsevier

Access to resources Recommend Favorite

Clinicopathologic correlation of patients with chronic renal allograft dysfunction

By Sumethkul V.   Jirakranont B.   Oralratmanee S.   Chalermsanyakorn P.  

Transplantation Proceedings, Vol. 32, Iss. 7, 2000-11 ,pp. : 1884-1885

Elsevier

Access to resources Recommend Favorite